Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in gastrointestinal stromal tumor.

Jonathan C Trent1, Robert S Benjamin

  • 1Department of Sarcoma Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

Current Opinion in Oncology
|May 25, 2006
PubMed
Summary

Recent advances in gastrointestinal stromal tumors (GIST) highlight targeted therapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Advances in Radiation Therapy for Primary Bone Malignancies.

Technology in cancer research & treatment·2026
Same author

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

JAMA oncology·2026
Same author

Primary Synovial Sarcoma of the Abdomen and Pelvis.

American journal of clinical oncology·2025
Same author

Tumor Genomics, Metastatic Patterns, and Prognosis in Leiomyosarcoma: A Single-Center Retrospective Cohort Study.

Cancers·2025
Same author

DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas.

Cancers·2025

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Gastrointestinal stromal tumors (GIST) have been studied for decades.
  • Significant progress in patient care for GIST emerged in the late 1990s.
  • The discovery of the critical role of Kit in GIST paved the way for targeted therapies.

Purpose of the Study:

  • To provide an update on significant gastrointestinal stromal tumor studies.
  • Emphasis on research published within the last two years.
  • To highlight recent breakthroughs in GIST understanding and treatment.

Main Methods:

  • Review of recent scientific literature on gastrointestinal stromal tumors.
  • Analysis of studies focusing on epidemiology, genetics, histopathology, and biology.
  • Examination of advancements in radiographic imaging for GIST.

Main Results:

  • The development of imatinib mesylate (Gleevec) represents a major success in targeted therapy for GIST.
  • Targeted therapy in GIST has spurred new insights into its epidemiology, genetics, and biology.
  • Recent studies have expanded our understanding of GIST across various scientific disciplines.

Conclusions:

  • Continued intensive research in gastrointestinal stromal tumors holds potential for revolutionary oncological paradigms.
  • Targeted therapies have transformed GIST treatment and understanding.
  • Further investigation may lead to paradigm shifts in oncology beyond GIST.

Related Experiment Videos